MAY 05, 2021 8:00 AM PDT

The Impact of SARS-CoV-2 Genomic Surveillance Locally, Nationally, and Globally

Speaker

Abstract

Date:  May 5, 2021

Time: 8:00am PDT, 11:00am EDT, 5:00pm CET

 

Emergence of genetic mutations within the SARS-CoV-2 genome that may enhance transmissibility, increase symptom severity or improve the virus’s ability to evade immunity produced by current vaccines, have raised concerns around the world.   Learn from two colleagues that have pivoted lab efforts to enable SARS-CoV-2 mutation surveillance at a local and national level.

 

Testing and Surveillance of SARS-CoV-2 Variants to Enable Safe Return to On-campus Learning

 

In March of 2020, like other Universities, Northeastern University (Boston, MA) moved all instruction online and shortly there after closed campus down.  Almost immediately after the University started to plan for its reopening in Fall of 2022.  In this presentation, we will briefly look at Northeastern Universities response to COVID-19 through testing as well as the importance of genomic surveillance as the number of variants reported increases.   

 

SARS CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high risk variants into the United Kingdom

 

Mandatory Day 2 and Day 8 PCR testing of international arrivals has been recently introduced by the UK Government to mitigate against the cross-border transmission of high risk SARS-CoV-2 variants. All positive Day 2 samples with cycle threshold (Ct) values of <30 (defined as equivalent to ~10,000-1,000 viral genome copies/ml) must undergo genomic sequencing. Oncologica is a participant in this testing program and utilizes a novel integrated test and sequence workflow to detect and identify variants. Here we have conducted a retrospective analysis of SARS-CoV-2 test data to determine the prevalence and variant type entering the UK.

 

 

Learning Objectives:

  • Learn how academic and public health laboratories are implementing SARS-CoV-2 genome sequencing for surveillance and tracking of variants within localized populations
  • Be introduced to contributions toward regional and national genomic surveillance efforts by private laboratories
  • Gain an understanding of the importance in having a strong national surveillance program in parallel with a robust network of local and regional labs to enable rapid, public health response to outbreaks.

 

 

Webinars will be available for unlimited on-demand viewing after live event.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
JUN 22, 2021 10:00 AM PDT
C.E. CREDITS
JUN 22, 2021 10:00 AM PDT
Date: June 22, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Antimicrobial resistance (AMR) has emerged as one of the principal public health problems of the 21st century. It threatens the effectiv...
Loading Comments...
Show Resources